47 related articles for article (PubMed ID: 22078627)
1. Re: Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein.
Atala A
J Urol; 2011 Dec; 186(6):2495. PubMed ID: 22078627
[No Abstract] [Full Text] [Related]
2. Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein.
Kang BH; Xia F; Pop R; Dohi T; Socolovsky M; Altieri DC
J Biol Chem; 2011 May; 286(19):16758-67. PubMed ID: 21454573
[TBL] [Abstract][Full Text] [Related]
3. AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins.
Yano M; Terada K; Mori M
J Cell Biol; 2003 Oct; 163(1):45-56. PubMed ID: 14557246
[TBL] [Abstract][Full Text] [Related]
4. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
Tahir A; Chahal HS; Korbonits M
Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
7. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
[TBL] [Abstract][Full Text] [Related]
10. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
11. AIP and its interacting partners.
Trivellin G; Korbonits M
J Endocrinol; 2011 Aug; 210(2):137-55. PubMed ID: 21454441
[TBL] [Abstract][Full Text] [Related]
12. Role of AIP and its homologue the blindness-associated protein AIPL1 in regulating client protein nuclear translocation.
van der Spuy J; Cheetham ME
Biochem Soc Trans; 2004 Aug; 32(Pt 4):643-5. PubMed ID: 15270697
[TBL] [Abstract][Full Text] [Related]
13. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
14. The aryl hydrocarbon receptor predisposes hepatocytes to Fas-mediated apoptosis.
Park KT; Mitchell KA; Huang G; Elferink CJ
Mol Pharmacol; 2005 Mar; 67(3):612-22. PubMed ID: 15550680
[TBL] [Abstract][Full Text] [Related]
15. AIP gene and familial isolated pituitary adenomas.
Ozfirat Z; Korbonits M
Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
[TBL] [Abstract][Full Text] [Related]
16. Modulation of aryl hydrocarbon receptor transactivation by carbaryl, a nonconventional ligand.
Boronat S; Casado S; Navas JM; Piña B
FEBS J; 2007 Jul; 274(13):3327-39. PubMed ID: 17553063
[TBL] [Abstract][Full Text] [Related]
17. Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor.
Vrzal R; Daujat-Chavanieu M; Pascussi JM; Ulrichova J; Maurel P; Dvorak Z
Eur J Pharmacol; 2008 Mar; 581(3):244-54. PubMed ID: 18177856
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures.
Stejskalova L; Vecerova L; Peréz LM; Vrzal R; Dvorak Z; Nachtigal P; Pavek P
Toxicol Sci; 2011 Sep; 123(1):26-36. PubMed ID: 21666223
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
[TBL] [Abstract][Full Text] [Related]
20. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
